Amanda Burgess is a veterinary industry regulatory affairs professional with 10 years of experience working alongside the USDA CVB. She is the acting VP of Regulatory Affairs at Genvax Technologies, a startup company making waves in the veterinary vaccine space and bringing the forefront of human vaccine technology to the animals sector. She serves on the Board of Directors for the Association of Veterinary Biologics Companies (AVBC), is a member of and participates in many working groups of the Animal Health Institute (AHI), and serves on the Advisory Board of NIAMRRE. With a strong background in veterinary science and biotechnology, she enjoys navigating the current regulations that exist for veterinary vaccines and biologics and actively participating in the melding of new regulations, especially for new and novel products.